BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 15378188)

  • 1. The incidence of inclusion of the sigmoid colon and small bowel in the planning target volume in radiotherapy for prostate cancer.
    De Meerleer GO; Villeirs GM; Vakaet L; Delrue LJ; De Neve WJ
    Strahlenther Onkol; 2004 Sep; 180(9):573-81. PubMed ID: 15378188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anatomic variations due to radical prostatectomy. Impact on target volume definition and dose-volume parameters of rectum and bladder.
    Sanguineti G; Castellone P; Foppiano F; Franzone P; Marcenaro M; Tognoni P; Bolognesi A; Ceresoli GL; Fiorino C
    Strahlenther Onkol; 2004 Sep; 180(9):563-72. PubMed ID: 15378187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective three-dimensional analysis about the impact of differences in the clinical target volume in prostate cancer irradiation on normal-tissue exposure. A potential for increasing the benefit/risk ratio.
    Hille A; Töws N; Schmidberger H; Hess CF
    Strahlenther Onkol; 2005 Dec; 181(12):789-95. PubMed ID: 16362789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Image-based 3D treatment planning for vaginal cylinder brachytherapy: dosimetric effects of bladder filling on organs at risk.
    Hung J; Shen S; De Los Santos JF; Kim RY
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):980-5. PubMed ID: 22138458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II trial for the optimisation of treatment position in the radiation therapy of prostate cancer.
    O'Neill L; Armstrong J; Buckney S; Assiri M; Cannon M; Holmberg O
    Radiother Oncol; 2008 Jul; 88(1):61-6. PubMed ID: 18453021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct segment aperture and weight optimization for intensity-modulated radiotherapy of prostate cancer.
    De Meerleer G; Vakaet L; De Gersem W; Villeirs G; De Neve W
    Strahlenther Onkol; 2004 Mar; 180(3):136-43. PubMed ID: 14991200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of calculation algorithm on dose distribution in irradiation of non-small cell lung cancer (NSCLC) collapsed cone versus pencil beam.
    Koelbl O; Krieger T; Haedinger U; Sauer O; Flentje M
    Strahlenther Onkol; 2004 Dec; 180(12):783-8. PubMed ID: 15592698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative radiation treatment for rectal cancer: comparison of target coverage and small bowel NTCP in conventional vs. 3D-conformal planning.
    Cella L; Ciscognetti N; Martin G; Liuzzi R; Punzo G; Solla R; Farella A; Salvatore M; Pacelli R
    Med Dosim; 2009; 34(1):75-81. PubMed ID: 19181259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Image-based three-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: dose-volume histograms of the bladder, rectum, sigmoid colon, and small bowel.
    Kim RY; Shen S; Duan J
    Brachytherapy; 2007; 6(3):187-94. PubMed ID: 17606413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of image-guided intensity-modulated radiotherapy with fiducials for localized prostate cancer including pelvic lymph nodes.
    Hsu A; Pawlicki T; Luxton G; Hara W; King CR
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):898-902. PubMed ID: 17459610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of planning margin on dosimetric quality in 131Cs permanent prostate brachytherapy.
    Li T; Fountain BL; Duffy EW
    Brachytherapy; 2010; 9(2):159-64. PubMed ID: 19853535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dose-escalation trial with the adaptive radiotherapy process as a delivery system in localized prostate cancer: analysis of chronic toxicity.
    Brabbins D; Martinez A; Yan D; Lockman D; Wallace M; Gustafson G; Chen P; Vicini F; Wong J
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):400-8. PubMed ID: 15667959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
    Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
    Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensity-modulated radiation therapy after hysterectomy: comparison with conventional treatment and sensitivity of the normal-tissue-sparing effect to margin size.
    Ahamad A; D'Souza W; Salehpour M; Iyer R; Tucker SL; Jhingran A; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1117-24. PubMed ID: 15990017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of interfractional set-up errors and intrafractional organ motions during IMRT for head and neck tumors to define an appropriate planning target volume (PTV)- and planning organs at risk volume (PRV)-margins.
    Suzuki M; Nishimura Y; Nakamatsu K; Okumura M; Hashiba H; Koike R; Kanamori S; Shibata T
    Radiother Oncol; 2006 Mar; 78(3):283-90. PubMed ID: 16564594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric advantages and superior treatment delivery efficiency of RapidArc over conventional intensity-modulated radiotherapy in high-risk prostate cancer involving seminal vesicles and pelvic nodes.
    Poon DM; Kam M; Leung CM; Chau R; Wong S; Lee WY; Wong KC; Yu B; Chan A
    Clin Oncol (R Coll Radiol); 2013 Dec; 25(12):706-12. PubMed ID: 23954261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in dose escalation using the process of adaptive radiotherapy combined with three-dimensional conformal or intensity-modulated beams for prostate cancer.
    Martinez AA; Yan D; Lockman D; Brabbins D; Kota K; Sharpe M; Jaffray DA; Vicini F; Wong J
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1226-34. PubMed ID: 11483333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical analysis of dose-volume and dose-wall histograms for rectal toxicity following 3D-CRT in prostate cancer.
    García-Vicente F; Zapatero A; Floriano A; Cruz-Conde A; Perez L; Marín A; Mínguez C; Torres JJ
    Med Phys; 2005 Aug; 32(8):2503-9. PubMed ID: 16193780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new method of incorporating systematic uncertainties in intensity-modulated radiotherapy optimization.
    Yang J; Mageras GS; Spirou SV; Jackson A; Yorke E; Ling CC; Chui CS
    Med Phys; 2005 Aug; 32(8):2567-79. PubMed ID: 16193787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of organ at risk definition on rectal dose-volume histograms in patients with prostate cancer undergoing external-beam radiotherapy.
    Boehmer D; Kuczer D; Badakhshi H; Stiefel S; Kuschke W; Wernecke KD; Budach V
    Strahlenther Onkol; 2006 May; 182(5):277-82. PubMed ID: 16673061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.